StockHotTips.com Hot Stock News & Alerts!


******************************************************************

Cavitation Technologies, Inc. (OTCBB: CVAT) has signed an agreement with Catalyst Partners, LLC located in Washington, D.C. CVAT will be working primarily with Dr. David McWhorter, Principal. Catalyst Partners will strive to open doors within the Government, identify Federal contracts, and help CVAT gain exposure with major US Corporations, which includes raising awareness of CVAT’s technology in various industries.

About Cavitation Technologies, Inc.
Cavitation Technologies, Inc. is a “Green-Tech” company, established in 2006 to become a world leader in the development of new cutting edge technologies for the vegetable oil refining, renewable fuel, petroleum, water treatment, wastewater sanitation, food and beverage, and chemical industries.
Visit Cavitation Technologies, Inc. (CVAT.OB) for more information at www.cavitationtechnologies.com

Organic Sales & Marketing Inc. (OTCBB: OGSM) is committed to bringing only the finest natural and environmentally friendly products to the global marketplace. OGSM mission is the ultimate safety of our children, pets, wildlife and planet
About Organic Sales & Marketing Inc.
Organic Sales and Marketing, Inc. engages in the sale and marketing of various natural and non-food products in the United States. It sells natural cleaners, including stain remover, odor control, glass cleaner, floor cleaner, degreaser, concrete cleaner, eyeglass cleaner, jewelry cleaner, surface prep, glue cleaner, natural insecticide-fungicide, organic soy candles, and organic fertilizers. The company sells its products to retail supermarkets; convenience stores; colleges; universities; laboratories; local, regional, and national government agencies; lawn and garden centers; and funeral industry. It also markets its products to sports teams and cigar catalog houses, as well as costume jewelry, sporting goods, hobby and craft, health, beauty and wellness, footwear, automotive, wine, and cocoa industries.
Visit Organic Sales & Marketing Inc. (OGSM.OB) for more information at http://www.organicsalesandmarketing.com

Power 3 Medical Products Inc. (OTCBB: PWRM) reported that 4 abstracts covering results from clinical validation trials of the NuroPro(R) AD test for Alzheimer’s disease were submitted to the 2010 annual meeting of the International Congress of Alzheimer’s Disease, taking place July 2010. The NuroPro AD test was developed to help clinicians distinguish patients with Alzheimer’s disease from “normal” individuals and patients with other neurological disorders. The test, developed by PWRM, is a panel of 57 blood serum protein biomarkers evaluated by biostatistical analysis to predict the probability a patient has Alzheimer’s disease. The test is intended to solve the critical challenge facing physicians, clinicians, and patients for quick, early stage, and accurate diagnosis of this debilitating disease as well as to provide guidance for therapy, and monitor treatment response.
PWRM has signed a definitive agreement to acquire all of the stock of StemTroniX Inc., a Texas corporation (”StemTroniX”).
PWRM plans to effectuate the acquisition of StemTroniX by merging a wholly-owned subsidiary of the Company with and into StemTroniX. StemTroniX will remain as the surviving company in the merger and will become a wholly-owned subsidiary of PWRM. The acquisition of StemTroniX is expected to be completed in April 2010.
About Power 3 Medical Products Inc.
Power 3 Medical Products Inc. is a leader in bio-medical research and the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets. PWRM’s patent-pending technologies are being used to develop screening and diagnostic tests for the early detection and prognosis of disease, identify protein biomarkers, and drug targets, and its diagnostic tests are targeted toward markets with critical unmet needs in areas including neurodegenerative disease (NuroPro) and breast cancer (BC-SeraPro). PWRM operates a state-of-the-art CLIA certified laboratory in The Woodlands (Houston), Texas and continues to evolve and enhance its IP portfolio, employing sensitive and specific combinations of biomarkers it has discovered from a broad range of diseases as the basis of highly selective blood-based tests for ALS, Alzheimer’s, and Parkinson’s diseases, breast cancer, and drug resistance.
Visit Power 3 Medical Products Inc. (PWRM.OB) for more information at www.Power3Medical.com
******************************************************************

***********Advertisement***********










.png)
.png)

.png)

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer
: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.Stock Hot Tips publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold StockHotTips.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) anticipates receiving sixty thousand dollars in 144 restricted stock for twelve months of advertisement services for Cavitation Technologies, Inc. (CVAT.OB). Crown Equity Holdings, Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for 30 days of advertisement services and has received an additional 1,000,000 shares 144 restricted stocks for 6 months of advertisement and disseminate news and $15,000 dollars for IR services for Power 3 Medical Products Inc. (PWRM.OB).
** The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings, Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.